Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
Key Information
Due Date: January 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Government
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
Firstly, the grant invites proposals for the development and implementation of potential pharmacological (drug-based) and non-pharmacological interventions. These interventions are targeted at cognitive and neuropsychiatric changes associated with age-related cognitive decline and both AD and Alzheimer's disease-related dementias (ADRD). The focus is on the entire spectrum of these diseases, from pre-symptomatic stages to more severe phases.
Secondly, the grant aims to stimulate studies that aim to improve the design and methods of these clinical trials, making them more efficient and effective. The inclusion of R01 Clinical Trial is optional.
Key Dates
Open Date: December 23, 2022
Application Due Date: January 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses